(Q36534701)

14 August 2017

1 reference

title

The role of progesterone receptors in meningioma (English)

1 reference

14 August 2017

S. M. Grunberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1683782

28 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1683782

28 October 2022

publication date

1 January 1991

1 reference

full work available at URL

14 August 2017

http://link.springer.com/content/pdf/10.1007/978-1-4615-3876-9_8.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Cancer Treatment and Research

28 October 2022

published in

1 reference

14 August 2017

volume

58

1 reference

14 August 2017

page(s)

127-137

1 reference

14 August 2017

cites work

Meningiomas: an update

1

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

28 October 2022

4

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

The effect of pregnancy on intracranial meningiomas occurring about the optic chiasm.

28 October 2022

5

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

The relapsing course of certain meningiomas in relation to pregnancy and menstruation

28 October 2022

6

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Brain tumour and pregnancy

28 October 2022

7

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Correlation between sex hormone binding and peritumoral edema in intracranial meningiomas

28 October 2022

10

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Association of breast cancer with meningioma.Report of two cases and review of the literature

28 October 2022

11

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Carcinoma of the breast and meningioma. Association and management

28 October 2022

12

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Breast cancer and meningioma

28 October 2022

13

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Nervous system neoplasms and primary malignancies of other sites. The unique association between meningiomas and breast cancer

28 October 2022

14

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Estrogen-receptor protein in intracranial meningiomas

28 October 2022

16

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Presence of sex steroid hormone receptors in meningioma tissue

28 October 2022

17

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Steroid receptor proteins in human meningiomas

28 October 2022

18

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Estrogen and progestin receptors in intracranial meningiomas.

28 October 2022

19

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Estrogen and progesterone receptors in meningiomas in relation to clinical and pathologic features

28 October 2022

20

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Presence of progesterone receptors and absence of oestrogen receptors in human intracranial meningioma cytosols

28 October 2022

21

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Estrogen- and progesterone-receptor proteins in intracranial tumors.

28 October 2022

22

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Intra-operative spinal cord monitoring during surgery for scoliosis using somatosensory evoked potentials.

28 October 2022

24

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Estrogen and progestin binding by cytosolic and nuclear fractions of human meningiomas

28 October 2022

25

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Hormonal steroid receptors in intracranial tumours and their relevance in hormone therapy

28 October 2022

26

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

High incidence of somatostatin receptors in human meningiomas: biochemical characterization

28 October 2022

27

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Cryostat section assay of oestrogen and progesterone receptors in meningiomas: a clinicopathological study

28 October 2022

28

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Correlation of meningioma hormone receptor status with hormone sensitivity in a tumor stem-cell assay

28 October 2022

29

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Estrogen and progestin receptors in intracranial tumors

28 October 2022

30

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

European Journal of Surgical Oncology

28 October 2022

31

13

303

IR Whittle

1987

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Gonadal steroid receptors in meningiomas

28 October 2022

32

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Steroid receptors in human brain and spinal cord tumors

28 October 2022

33

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Steroid hormone binding macromolecules in meningiomas failure to meet criteria of specific receptors

28 October 2022

36

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen

28 October 2022

37

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance.

28 October 2022

38

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

28 October 2022

40

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Localization of progesterone receptor with monoclonal antibodies to the human progestin receptor

28 October 2022

41

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Immunocytochemical evidence of progesterone receptors in human meningiomas

28 October 2022

42

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Assay of oestrogen and progestin receptors in human meningioma cytosols using immunological methods

28 October 2022

43

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Modulation of meningioma cell growth by sex steroid hormones in vitro

28 October 2022

44

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Hormonal manipulation of meningiomas in vitro

28 October 2022

45

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Oestrogen and progesterone sensitivity in cultured meningioma cells

28 October 2022

46

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Effect of MPA on growth of primary meningioma cells in monolayer tissue culture

28 October 2022

47

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Hormonotherapy of meningiomas with medroxyprogesterone acetate. Immunohistochemical demonstration of the effect of medroxyprogesterone acetate on growth fractions of meningioma cells using the monoclonal antibody Ki-67.

28 October 2022

48

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

RU486, a progestin and glucocorticoid antagonist, inhibits the growth of breast cancer cells via the progesterone receptor

28 October 2022

49

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice

28 October 2022

50

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Androgen receptors in meningiomas

28 October 2022

51

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Somatostatin suppression of meningioma cell proliferation in vitro

28 October 2022

54

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Antiestrogenic therapy of meningiomas--a pilot study.

28 October 2022

55

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Steroid receptor status difference in recurrent intracranial meningioma and breast cancer in the same patient

28 October 2022

56

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Effect of MPA on receptor status of meningioma cytosols

28 October 2022

57

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Hormone treatment of meningiomas: lack of response to medroxyprogesterone acetate (MPA). A pilot study of five cases

28 October 2022

58

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Lack of efficacy of megestrol acetate in the treatment of unresectable meningioma

28 October 2022

59

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone

28 October 2022

60

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-3876-9_8

28 October 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1683782

28 October 2022

1 reference